TRDA
Price
$8.02
Change
-$0.78 (-8.86%)
Updated
Apr 3 closing price
Capitalization
300.76M
34 days until earnings call
VYNE
Price
$1.67
Change
+$0.03 (+1.83%)
Updated
Apr 3 closing price
Capitalization
24.94M
Ad is loading...

TRDA vs VYNE

Header iconTRDA vs VYNE Comparison
Open Charts TRDA vs VYNEBanner chart's image
Entrada Therapeutics
Price$8.02
Change-$0.78 (-8.86%)
Volume$239.88K
Capitalization300.76M
VYNE Therapeutics
Price$1.67
Change+$0.03 (+1.83%)
Volume$102.19K
Capitalization24.94M
TRDA vs VYNE Comparison Chart
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. VYNE commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a StrongBuy and VYNE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (TRDA: $8.02 vs. VYNE: $1.67)
Brand notoriety: TRDA and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 208% vs. VYNE: 78%
Market capitalization -- TRDA: $300.76M vs. VYNE: $24.94M
TRDA [@Biotechnology] is valued at $300.76M. VYNE’s [@Biotechnology] market capitalization is $24.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 1 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 1 green, 4 red.
According to our system of comparison, TRDA is a better buy in the long-term than VYNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 4 TA indicator(s) are bullish while VYNE’s TA Score has 5 bullish TA indicator(s).

  • TRDA’s TA Score: 4 bullish, 4 bearish.
  • VYNE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VYNE is a better buy in the short-term than TRDA.

Price Growth

TRDA (@Biotechnology) experienced а -19.48% price change this week, while VYNE (@Biotechnology) price change was -6.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

TRDA is expected to report earnings on May 08, 2025.

VYNE is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($301M) has a higher market cap than VYNE($24.9M). TRDA has higher P/E ratio than VYNE: TRDA (4.76) vs VYNE (0.71). VYNE YTD gains are higher at: -50.149 vs. TRDA (-53.615). TRDA has higher annual earnings (EBITDA): 50.8M vs. VYNE (-43.63M). TRDA has more cash in the bank: 420M vs. VYNE (61.5M). VYNE has less debt than TRDA: VYNE (99K) vs TRDA (59.2M). TRDA has higher revenues than VYNE: TRDA (211M) vs VYNE (501K).
TRDAVYNETRDA / VYNE
Capitalization301M24.9M1,209%
EBITDA50.8M-43.63M-116%
Gain YTD-53.615-50.149107%
P/E Ratio4.760.71672%
Revenue211M501K42,116%
Total Cash420M61.5M683%
Total Debt59.2M99K59,798%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRDAVYNE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOCL2.820.72
+34.29%
Local Bounti Corp
UUUU3.63-0.14
-3.71%
Energy Fuels
BCO86.16-4.58
-5.05%
Brink's Company (The)
WIT2.92-0.17
-5.50%
Wipro Limited
JMIA1.98-0.22
-10.00%
Jumia Technologies AG

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-8.86%
CRNX - TRDA
51%
Loosely correlated
-8.03%
RXRX - TRDA
50%
Loosely correlated
-9.07%
ATXS - TRDA
49%
Loosely correlated
-6.70%
ARCT - TRDA
47%
Loosely correlated
-7.01%
IMNM - TRDA
46%
Loosely correlated
-7.00%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with ELVN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+1.83%
ELVN - VYNE
33%
Loosely correlated
+0.86%
TRDA - VYNE
33%
Poorly correlated
-8.86%
KOD - VYNE
33%
Poorly correlated
-10.11%
SPRB - VYNE
32%
Poorly correlated
-0.10%
VTGN - VYNE
31%
Poorly correlated
-4.60%
More